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The authentication of mammalian cell cultures and their subpopulations are of tremendous 
demand in biotechnology and cell therapy. However, current techniques are either not 
efficient or can be very complex and expensive. Here we report a simple and 
straightforward approach for authentication of biological cells and their subpopulations 
with high speed, high throughput, low sample cost, and high sensitivity. We discovered that 
cell cultures treated with protease at soft, “non-killing” conditions release fragments of cell 
surface proteins, which composition is a strong characteristic of the cells. Mass 
spectrometric analysis of the released fragments allows a direct comparison of the 
produced mass spectrum with the mass spectrum of known cells. As an example, we 
applied this technique to verify subpopulations of human fibroblasts which have different 
origins and exhibit different medical characteristics.  
 
Cultivated in vitro cells have a great commercial value in a wide range of therapeutic 
applications, among these are: tissue engineering applications,1,2  regenerative medicine,3  cell-
based anti-cancer vaccination,4  burns treatment,5 etc. However, cultivated cells indicate that 
cross-contamination between cell lines is widely prevalent, and continues to be a major 
problem6–9. From the existing estimates, it is know that during the cultivation process up to 36% 
of cell lines have already a different origin from their initial cell lines.10  
From the known cell authentication methods,11 short tandem repeat profiling (DNA 
fingerprinting)10 is considered to be the most powerful method that provides an international 
reference standard for authentication of human cell lines.12 However, this method exhibits some 
limitations: DNA fingerprinting is usually so complex and labor intensive that the cost of 
fingerprinting can be up to $200 for each cell line,12 moreover DNA fingerprinting profiles could 
be very difficult to interpret and store in computer databases. Another major limitation is that the 
common cell culture protocols may dramatically affect the fingerprinting profile of certain cell 
lines thus making the definition of their origin improbable13. The control of cell propagation by 
DNA fingerprinting, when following a GTP (Good Tissue Practice) protocol, may increase the 
cost of end-product substantially.  
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Also important application where the authentication of cell subpopulations is essential is 
primary cultures in cell therapy. For example, fibroblast or cancer cell primary cultures have an 
extremely high potential value in therapeutic applications and exhibit different useful properties 
depending on its origin.4,14-18  
Thus, a simple and routine method for identification of cells and their subpopulations is 
required. Direct mass-spectrometry is proven to be a good method for that. Previously, a fast and 
simple approach for cell identifying was proposed where mammalian cells are lysed with 2,5-
dihydroxybenzoic acid (DHB) and analyzed by matrix assisted laser desorption ionization time-
of-flight (MALDI TOF) mass spectrometry. Using this unique mass spectral protein profile the 
authors were able to differentiate among several different mammalian cell lines.19  
Here we report a simple and straightforward approach for authentication of mammalian 
cells and their subpopulations with high speed, high throughput, low sample cost, and high 
sensitivity. We discovered that cell cultures treated with protease at soft, “non-killing” 
conditions release fragments of cell surface proteins, which composition is a strong characteristic 
of the cells (see Fig.1). Mass spectrometric analysis of the released fragments allows a direct 
comparison of the produced mass spectrum with the mass spectrum of a known cells. Thus, 
analyzing peptides instead of the whole cell lysate avoids contamination of mass spectra by high 
abundant and common for all mammalian cells house-keeping proteins, lipids, nuclear acids and 
other intracellular contents. As a result, obtained peptide samples ideally suit for MALDI mass 
analysis, which provides enough information to differentiate cells on subpopulation level. 
In this study we applied this technique to authenticate different types of human 
fibroblasts. All fibroblasts have spindle-like morphology in cultures, but exhibit different 
medical properties according to their origin: dermal papilla fibroblasts are trichogen cells,15 
adipose-derived fibroblasts are pluripotent,16 fetal skin fibroblasts have high potency to 
proliferate and are well suited for allogenic cell therapy,17 wherever adult skin fibroblasts are 
well suited for autologouse cell therapy.18 Fibroblast cultures could be a very good model to test 
new cell authentication methods, because they have an identical morphology and are propagated 
under the same conditions.  
Fibroblast primary cultures were analyzed by mass spectrometry according to the 
following protocol (see Methods). Mass spectra were then compared by hierarchical cluster 
analysis. Figure 2 shows obtained hierarchical tree plot where all mass spectra were split into 
two main groups: fetal and non-fetal cells. Mass spectra of non-fetal cells were then split into 
subgroups according to the cell origin: skin fibroblasts and a group of other non-fetal cells, 
which was again divided in to subgroups of dermal papilla fibroblasts and adipose-derived 
fibroblasts. Thus all mass spectra were separated into groups and subgroups according to cells 
origin.  
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Obtained data allows to define different characteristic of fibroblasts such as: fetality, 
pluripotency or trichogen properties. So offered protocol can be considered as a new cell 
authentication technique suitable for primary cultures and their subpopulations. Apart from all 
other methods only this satisfies all the criteria below: 
High throughput: 10 min per sample.  
High sensitivity: 500 cells are enough for the analysis and this parameter mainly is 
limited by mass spectrometer sensitivity; note that all cells utilized in this analysis can be 
returned to cultivation, which is extremely important when only few cells are available for the 
analysis.  
Full integration in cell cultivation technology: cell treatment with trypsin in soft 
conditions is widespread in adherent cell culture maintain protocols for collecting cells from the 
surface and their further subcultivation. Thus samples of used harvesting solution can be directly 
used for analysis. 
Low cost: ~15$ per sample, that is much lower in comparison with all other offered 
techniques. 
Easy data processing: mass spectra return numerical results, which avoids human factor 
in cells authentication.  
This technique can also be applied for large-scale applications: sample preparation, mass 
spectrometry analysis can be easily automated by available on the market instruments.  
Obtained by offered technique mass spectra characterize cells in a new, previously not 
described manner. For this reason the term ‘cell proteomic footprint’ was introduced for such 
mass-spectra. Cell culture foot printing offers an excellent alternative to traditional laboratory 
authentication methods for cells and cells subpopulations. Because the proteomic footprint 
specific for each individual cell cultures, it is useful not only to authenticate cell culture but also 
to monitor their identity during propagation in a laboratory. The speed, robustness and minimal 
costs of sample preparation and measurement for this method makes it exceptionally well suited 
for routine and high-throughput analysis. 
 
METHODS 
42 primary cultures from the Cell Culture Collection (ZAO BioBohemia, Russia) of 
dermal papilla fibroblasts, adipose-derived fibroblasts, adult skin and fetal skin fibroblast 
cultures, which were initiated as described by Lü et al.15, Zuk et al.16, Rittie and Fisher20, and 
Salvatori et al.21, respectively. Primary cultures were cultivated in identical conditions (DMEM, 
10% FBS, 5% СО2, 37ºС) and between passage 3 and 5 were analyzed by mass spectrometry 
according to the following protocol:  
1. Cells were washed at least three times with 0.9% NaCl to remove serum traces. 
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2. Cells were quickly rinsed with cold trypsin solution (4-8°C, 1 µg/ml, trypsin activity 
3000 U/mg; Sigma, USA) prepared in 0.9% NaCl followed by cell incubation at 37ºC 
and >95% humidity.  
3. Between 5 and 7 min of incubation cells were rinsed with 0.9% NaCl (1 ml per 25 cm2 of 
flask surface) to wash off protein fragments released from cell surfaces. Cells at this 
moment must be attached to flask bottom and have a round shape (see Fig.1). If some 
cells were detached from flask surface the samples were quickly centrifuged to remove 
cells from NaCl solution. 
4. Obtained NaCl solution with protein fragments was desalted by using ZipTipС18 
(Millipore Corp., USA) according to protocol of the manufacturer (Millipore Corp., 
USA). MALDI samples were prepared using a standard “dried droplet” method with 
2,5-dihydroxybenzoic acid (DHB) as a matrix. All mass spectra were acquired on a 
MicroFLEX MALDI-TOF mass spectrometer (Bruker Daltonik, Germany) in linear 
positive ion mode.   
The sets of the obtained mass spectra were encoded into binary format, where ‘one’ – is a 
presence of a measured peptide mass in the spectrum, ‘zero’ – is the absence one. Binary 
encoded mass spectra were partitioned into different groups by hierarchical cluster analysis using 
Ward method and correlations between spectra as a distance matrix.  
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Figure 1.  Main steps of cell culture proteomic footprinting. 
Culture of adherent cells after washing from traces of culture medium is treated with protease at 
conditions nonkilling for cells. Released fragments from cell surface proteins are collected and 
submitted to mass spectrometry. The set of obtained peptide molecular weights represents cell 
culture proteomic footprint.    
 
 
Figure 2. Cluster analysis of 42 footprints obtained for fibroblasts primary cultures. 
Fibroblast cultures were treated with trypsin at nonkilling for cells conditions. The masses of 
peptides, released from cell surfaces, were measured by mass spectrometry. Obtained  mass 
spectra (cell proteomic footprints) were encoded in binary format, where ‘one’ is a presence of 
measured peptide mass in spectrum and vertical dash in figure, ‘zero’ - is the absence one. 
Footprints were clusterized using Ward method. Footprints of dermal papilla fibroblasts, 
adipose-derived fibroblasts, skin and fetal skin fibroblasts form separate clusters due to their 
similarity. The length of branches of hierarchical tree reflects the distance between footprints in 
similarity units. 
 
 


